Form 4: Director Gary Ellis Increases Stake in Inspire Medical

Director Gary Lee Ellis acquired 518 shares of Inspire Medical Systems, Inc. common stock in lieu of cash director fees.

Summary

• Director Gary Lee Ellis acquired 518 shares of common stock on April 15, 2026.
• The shares were issued at a price of $52.07 per share.
• The acquisition was made in lieu of cash compensation pursuant to the company's Non-Employee Director Compensation Policy.
• Following this transaction, the director's total beneficial ownership is 7,276 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation that does not signal a change in company strategy or financial health.

Positives

• Demonstrates alignment of interest between the director and shareholders through equity ownership.
• Reflects confidence in the company's long-term value by opting for stock over cash compensation.

Negatives

• None identified.

Risks

• Market price volatility of INSP common stock.

Future Outlook

Not applicable as this is a routine director compensation disclosure.

Management Comments

• The transaction represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Industry Context

StockSavvy.ai notes that it is common practice for medical device companies to offer equity-based compensation to directors to preserve cash and ensure long-term alignment with corporate performance.

Comparison to Industry Standards

• The practice of issuing stock in lieu of cash fees is standard corporate governance for mid-cap healthcare companies.
• The transaction size is consistent with typical director compensation packages for companies of similar market capitalization.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard compensation arrangement.

Next Steps

• No future actions or milestones mentioned.

Key Dates

Keywords

Inspire Medical Systems, INSP, Director Compensation, Insider Trading, Form 4, Equity Ownership